ZNF266
gene geneOn this page
Also known as HZF1
Summary
ZNF266 (zinc finger protein 266, HGNC:13059) is a protein-coding gene on chromosome 19p13.2, encoding Zinc finger protein 266 (Q14584). May be involved in transcriptional regulation.
This gene encodes a protein containing many tandem zinc-finger motifs. Zinc fingers are protein or nucleic acid-binding domains, and may be involved in a variety of functions, including regulation of transcription. This gene is located in a cluster of similar genes encoding zinc finger proteins on chromosome 19. Alternative splicing results in multiple transcript variants for this gene.
Source: NCBI Gene 10781 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 101 total
- MANE Select transcript:
NM_001370374
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:13059 |
| Approved symbol | ZNF266 |
| Name | zinc finger protein 266 |
| Location | 19p13.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | HZF1 |
| Ensembl gene | ENSG00000174652 |
| Ensembl biotype | protein_coding |
| OMIM | 604751 |
| Entrez | 10781 |
Gene structure
Transcript identifiers
Ensembl transcripts: 33 — 31 protein_coding, 2 retained_intron
ENST00000588221, ENST00000588933, ENST00000590306, ENST00000591213, ENST00000592292, ENST00000592904, ENST00000648978, ENST00000651268, ENST00000859744, ENST00000859745, ENST00000859746, ENST00000859747, ENST00000859748, ENST00000859749, ENST00000859750, ENST00000859751, ENST00000859752, ENST00000859753, ENST00000859754, ENST00000859755, ENST00000859756, ENST00000859757, ENST00000859758, ENST00000927991, ENST00000927992, ENST00000927993, ENST00000948585, ENST00000948586, ENST00000948587, ENST00000948588, ENST00000948589, ENST00000948590, ENST00000948591
RefSeq mRNA: 29 — MANE Select: NM_001370374
NM_001271314, NM_001370374, NM_001370375, NM_001370376, NM_001370377, NM_001370378, NM_001370379, NM_001370380, NM_001370381, NM_001370382, NM_001370383, NM_001370384, NM_001370385, NM_001370386, NM_001370387, NM_001370388, NM_001370389, NM_001370390, NM_001370391, NM_001370392, NM_001370393, NM_001370394, NM_001370395, NM_001370396, NM_001370397, NM_001370398, NM_001370399, NM_001370400, NM_006631
CCDS: CCDS12213, CCDS92507
Canonical transcript exons
ENST00000592904 — 11 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001199937 | 9415654 | 9415742 |
| ENSE00001215203 | 9435108 | 9435193 |
| ENSE00001516774 | 9433668 | 9433786 |
| ENSE00001516775 | 9434075 | 9434235 |
| ENSE00001741110 | 9417828 | 9417908 |
| ENSE00002923295 | 9434798 | 9434859 |
| ENSE00003832112 | 9419217 | 9419299 |
| ENSE00003834677 | 9412429 | 9414720 |
| ENSE00003837314 | 9420065 | 9420218 |
| ENSE00003839325 | 9435284 | 9435573 |
| ENSE00003840867 | 9418505 | 9418631 |
Expression profiles
Bgee: expression breadth ubiquitous, 289 present calls, max score 96.63.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 13.7799 / max 137.5736, expressed in 1765 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 179003 | 8.1676 | 1689 |
| 179004 | 5.6123 | 1605 |
Top tissues by expression
295 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| granulocyte | CL:0000094 | 96.63 | gold quality |
| visceral pleura | UBERON:0002401 | 94.54 | gold quality |
| tibia | UBERON:0000979 | 94.10 | gold quality |
| pleura | UBERON:0000977 | 93.75 | gold quality |
| spleen | UBERON:0002106 | 93.57 | gold quality |
| parietal pleura | UBERON:0002400 | 93.44 | gold quality |
| mucosa of stomach | UBERON:0001199 | 93.32 | gold quality |
| superficial temporal artery | UBERON:0001614 | 93.31 | gold quality |
| trabecular bone tissue | UBERON:0002483 | 92.65 | gold quality |
| hair follicle | UBERON:0002073 | 92.55 | gold quality |
| corpus epididymis | UBERON:0004359 | 92.47 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 92.36 | gold quality |
| cardia of stomach | UBERON:0001162 | 92.25 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 92.20 | gold quality |
| lymph node | UBERON:0000029 | 92.18 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 92.11 | gold quality |
| body of uterus | UBERON:0009853 | 91.88 | gold quality |
| skin of hip | UBERON:0001554 | 91.57 | gold quality |
| left ovary | UBERON:0002119 | 91.49 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 91.47 | gold quality |
| right ovary | UBERON:0002118 | 91.40 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 91.36 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 91.26 | gold quality |
| skin of abdomen | UBERON:0001416 | 91.20 | gold quality |
| skin of leg | UBERON:0001511 | 91.11 | gold quality |
| rectum | UBERON:0001052 | 90.97 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 90.89 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 90.88 | gold quality |
| lower esophagus | UBERON:0013473 | 90.88 | gold quality |
| left uterine tube | UBERON:0001303 | 90.86 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-CURD-89 | no | 321.61 |
| E-ANND-3 | no | 4.16 |
Regulation
Is transcription factor: yes
Downstream targets (CollecTRI)
2 targets.
| Target | Regulation |
|---|---|
| KIT | |
| ZNF266 |
Upstream regulators (CollecTRI, top): MEF2A, ZNF266
miRNA regulators (miRDB)
55 targeting ZNF266, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4262 | 100.00 | 73.26 | 3931 |
| HSA-MIR-8485 | 100.00 | 77.57 | 4731 |
| HSA-MIR-6833-3P | 100.00 | 70.63 | 3197 |
| HSA-MIR-4768-5P | 100.00 | 69.49 | 2861 |
| HSA-MIR-6873-3P | 100.00 | 71.42 | 2626 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-181A-5P | 99.99 | 72.96 | 2995 |
| HSA-MIR-181B-5P | 99.99 | 72.97 | 2996 |
| HSA-MIR-181C-5P | 99.99 | 72.95 | 2996 |
| HSA-MIR-181D-5P | 99.99 | 73.04 | 2997 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-3667-3P | 99.99 | 67.17 | 1636 |
| HSA-MIR-3692-3P | 99.98 | 70.27 | 2139 |
| HSA-MIR-545-3P | 99.95 | 70.74 | 2783 |
| HSA-MIR-552-5P | 99.93 | 68.56 | 1583 |
| HSA-MIR-515-5P | 99.92 | 69.82 | 2343 |
| HSA-MIR-519E-5P | 99.92 | 69.62 | 2358 |
| HSA-MIR-7845-5P | 99.88 | 64.88 | 771 |
| HSA-MIR-3941 | 99.86 | 70.54 | 2735 |
| HSA-MIR-4713-5P | 99.78 | 67.80 | 1794 |
| HSA-MIR-4446-5P | 99.72 | 69.19 | 2544 |
| HSA-MIR-4755-5P | 99.71 | 70.34 | 2716 |
| HSA-MIR-5006-3P | 99.71 | 70.26 | 2728 |
| HSA-MIR-3059-5P | 99.70 | 69.93 | 2491 |
| HSA-MIR-519A-3P | 99.67 | 71.67 | 1868 |
| HSA-MIR-519B-3P | 99.67 | 71.67 | 1868 |
| HSA-MIR-519C-3P | 99.67 | 71.67 | 1870 |
| HSA-MIR-580-3P | 99.67 | 69.23 | 1841 |
| HSA-MIR-4527 | 99.66 | 67.43 | 714 |
| HSA-MIR-6503-5P | 99.62 | 66.96 | 597 |
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Zfp266 | ENSMUSG00000060510 |
| rattus_norvegicus | Zfp266 | ENSRNOG00000034037 |
| drosophila_melanogaster | CG2712 | FBGN0024975 |
| drosophila_melanogaster | Phs | FBGN0036522 |
| drosophila_melanogaster | CG3281 | FBGN0260741 |
Paralogs (62): ZNF582 (ENSG00000018869), ZNF264 (ENSG00000083844), ZNF343 (ENSG00000088876), ZNF684 (ENSG00000117010), ZNF133 (ENSG00000125846), ZNF557 (ENSG00000130544), ZNF337 (ENSG00000130684), ZNF20 (ENSG00000132010), ZFP37 (ENSG00000136866), ZNF614 (ENSG00000142556), KRBOX4 (ENSG00000147121), ZNF599 (ENSG00000153896), ZNF19 (ENSG00000157429), ZNF589 (ENSG00000164048), PRDM9 (ENSG00000164256), ZNF180 (ENSG00000167384), ZNF558 (ENSG00000167785), ZNF35 (ENSG00000169981), ZNF778 (ENSG00000170100), ZNF439 (ENSG00000171291), ZNF440 (ENSG00000171295), ZNF556 (ENSG00000172000), ZNF554 (ENSG00000172006), ZNF596 (ENSG00000172748), ZNF80 (ENSG00000174255), ZNF25 (ENSG00000175395), ZNF77 (ENSG00000175691), ZNF169 (ENSG00000175787), ZNF404 (ENSG00000176222), ZNF491 (ENSG00000177599), ZNF620 (ENSG00000177842), ZNF619 (ENSG00000177873), ZNF875 (ENSG00000181666), ZNF329 (ENSG00000181894), ZFP90 (ENSG00000184939), ZNF566 (ENSG00000186017), ZNF529 (ENSG00000186020), ZNF749 (ENSG00000186230), ZNF555 (ENSG00000186300), ZNF70 (ENSG00000187792)
Protein
Protein identifiers
Zinc finger protein 266 — Q14584 (reviewed: Q14584)
Alternative names: Zinc finger protein HZF1
All UniProt accessions (2): Q14584, A0A3F2YPB8
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
RefSeq proteins (29): NP_001258243, NP_001357303, NP_001357304, NP_001357305, NP_001357306, NP_001357307, NP_001357308, NP_001357309, NP_001357310, NP_001357311, NP_001357312, NP_001357313, NP_001357314, NP_001357315, NP_001357316, NP_001357317, NP_001357318, NP_001357319, NP_001357320, NP_001357321, NP_001357322, NP_001357323, NP_001357324, NP_001357325, NP_001357326, NP_001357327, NP_001357328, NP_001357329, NP_006622 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR050752 | C2H2-ZF_domain | Family |
Pfam: PF00096
UniProt features (19 total): zinc finger region 14, chain 1, domain 1, region of interest 1, sequence variant 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q14584-F1 | 68.88 | 0.27 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 136 (showing top):
MORF_MSH3, MORF_BRCA1, MORF_RAD51L3, MODULE_313, MODULE_205, CADWELL_ATG16L1_TARGETS_DN, MORF_ATF2, MORF_BCL2L11, IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR, MILI_PSEUDOPODIA_CHEMOTAXIS_DN, BROWNE_HCMV_INFECTION_14HR_UP, MORF_PTEN, MORF_KDR, chr19p13, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING
GO Biological Process (3): negative regulation of transcription by RNA polymerase II (GO:0000122), regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (7): RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872), sequence-specific double-stranded DNA binding (GO:1990837)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of transcription by RNA polymerase II | 2 |
| transcription by RNA polymerase II | 2 |
| negative regulation of DNA-templated transcription | 1 |
| regulation of DNA-templated transcription | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| transcription cis-regulatory region binding | 1 |
| chromatin | 1 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1 |
| DNA-binding transcription factor activity | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| double-stranded DNA binding | 1 |
| sequence-specific DNA binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
598 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF266 | CCDC163 | A0A0D9SF12 | 594 |
| ZNF266 | ZPR1 | O75312 | 559 |
| ZNF266 | GPR15 | P49685 | 442 |
| ZNF266 | CLLU1-AS1 | Q5K130 | 414 |
| ZNF266 | SP140L | Q9H930 | 391 |
| ZNF266 | YJEFN3 | A6XGL0 | 374 |
| ZNF266 | SLFN5 | Q08AF3 | 367 |
| ZNF266 | ZNF738 | Q8NE65 | 359 |
| ZNF266 | SAMD10 | Q9BYL1 | 359 |
| ZNF266 | NOAZFP | Q9Y3S2 | 348 |
| ZNF266 | TMEM161A | Q9NX61 | 336 |
| ZNF266 | ZNF414 | Q96IQ9 | 330 |
| ZNF266 | ZMYND11 | Q15326 | 326 |
| ZNF266 | CCDC126 | Q96EE4 | 324 |
| ZNF266 | WDR54 | Q9H977 | 322 |
IntAct
54 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CEP70 | ZNF266 | psi-mi:“MI:0915”(physical association) | 0.720 |
| ZNF266 | MDFI | psi-mi:“MI:0915”(physical association) | 0.720 |
| ZNF266 | CEP70 | psi-mi:“MI:0915”(physical association) | 0.720 |
| MDFI | ZNF266 | psi-mi:“MI:0915”(physical association) | 0.720 |
| ZNF266 | MTUS2 | psi-mi:“MI:0915”(physical association) | 0.670 |
| TRIM41 | ZNF266 | psi-mi:“MI:0915”(physical association) | 0.600 |
| ZNF266 | TRIM41 | psi-mi:“MI:0915”(physical association) | 0.600 |
| ZNF266 | RANGRF | psi-mi:“MI:0915”(physical association) | 0.590 |
| KRTAP5-9 | ZNF266 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP10-7 | ZNF266 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF266 | KRTAP10-7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRT40 | ZNF266 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF266 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (19): ZNF266 (Two-hybrid), ZNF266 (Two-hybrid), CEP70 (Two-hybrid), TRIM41 (Two-hybrid), KRT40 (Two-hybrid), KRTAP10-7 (Two-hybrid), KRTAP10-3 (Two-hybrid), RANGRF (Affinity Capture-MS), ZNF266 (Two-hybrid), ZNF266 (Two-hybrid), ZNF266 (Two-hybrid), ZNF266 (Two-hybrid), KRTAP10-8 (Two-hybrid), CYSRT1 (Two-hybrid), RANGRF (Affinity Capture-MS)
ESM2 similar proteins: A2VDP4, A6NHJ4, D3ZVT0, O60765, O75123, P17097, P51508, P52738, Q02975, Q06730, Q0VGE8, Q14584, Q14590, Q2M218, Q2M3W8, Q2M3X9, Q2TL60, Q32KN0, Q3MIS6, Q4V8A8, Q5HY98, Q5HYK9, Q5MYW4, Q5RBX0, Q5VIY5, Q61751, Q61967, Q6GQR8, Q6P2D0, Q7TSH9, Q7Z3I7, Q86UD4, Q86Y25, Q8BFS8, Q8BQC8, Q8IZ26, Q8N184, Q8N782, Q8N9F8, Q8TF47
Diamond homologs: A0JPL0, A1L1L7, A2A761, A2VDP4, A3KN36, A6QLU5, A6QPT6, A7MBI1, A8MT65, B2RXC5, E9PYI1, E9Q8G5, O75290, O94892, O95780, P10076, P17014, P17023, P17025, P17030, P17032, P17098, P51523, P51814, P52736, P52742, P58317, Q02975, Q06730, Q06732, Q08DG8, Q0VCB0, Q13360, Q14584, Q14587, Q14590, Q147U1, Q16587, Q29RZ4, Q2M218
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
101 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 95 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1358 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:9415647:ATCTT:A | donor_loss | 1.0000 |
| 19:9415648:TCTTA:T | donor_loss | 1.0000 |
| 19:9415649:CTTA:C | donor_loss | 1.0000 |
| 19:9415650:TTACC:T | donor_loss | 1.0000 |
| 19:9415651:T:TG | donor_loss | 1.0000 |
| 19:9415652:A:AC | donor_gain | 1.0000 |
| 19:9415652:A:C | donor_loss | 1.0000 |
| 19:9415653:C:CC | donor_gain | 1.0000 |
| 19:9415743:C:CC | acceptor_gain | 1.0000 |
| 19:9417825:CA:C | donor_loss | 1.0000 |
| 19:9417826:A:AT | donor_loss | 1.0000 |
| 19:9417905:TATC:T | acceptor_gain | 1.0000 |
| 19:9417908:CC:C | acceptor_loss | 1.0000 |
| 19:9417908:CCTG:C | acceptor_gain | 1.0000 |
| 19:9417909:C:CC | acceptor_gain | 1.0000 |
| 19:9418504:CCTA:C | donor_gain | 1.0000 |
| 19:9419299:CCTCA:C | acceptor_gain | 1.0000 |
| 19:9419303:A:C | acceptor_gain | 1.0000 |
| 19:9435100:GTACT:G | donor_loss | 1.0000 |
| 19:9435102:ACT:A | donor_loss | 1.0000 |
| 19:9435103:CTC:C | donor_loss | 1.0000 |
| 19:9435104:TCAC:T | donor_loss | 1.0000 |
| 19:9435105:CACCG:C | donor_loss | 1.0000 |
| 19:9435106:A:AC | donor_gain | 1.0000 |
| 19:9435106:ACC:A | donor_loss | 1.0000 |
| 19:9435107:C:CC | donor_gain | 1.0000 |
| 19:9435107:CCG:C | donor_gain | 1.0000 |
| 19:9414717:CTAT:C | acceptor_gain | 0.9900 |
| 19:9415637:AT:A | donor_gain | 0.9900 |
| 19:9415738:TGAAG:T | acceptor_gain | 0.9900 |
AlphaMissense
4097 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:9413674:A:C | F417L | 0.999 |
| 19:9413674:A:T | F417L | 0.999 |
| 19:9413676:A:G | F417L | 0.999 |
| 19:9413563:G:C | H454Q | 0.998 |
| 19:9413563:G:T | H454Q | 0.998 |
| 19:9413590:A:C | F445L | 0.998 |
| 19:9413590:A:T | F445L | 0.998 |
| 19:9413592:A:G | F445L | 0.998 |
| 19:9413758:A:C | F389L | 0.998 |
| 19:9413758:A:T | F389L | 0.998 |
| 19:9413760:A:G | F389L | 0.998 |
| 19:9413842:G:C | F361L | 0.998 |
| 19:9413842:G:T | F361L | 0.998 |
| 19:9413844:A:G | F361L | 0.998 |
| 19:9413338:G:C | F529L | 0.997 |
| 19:9413338:G:T | F529L | 0.997 |
| 19:9413340:A:G | F529L | 0.997 |
| 19:9413390:C:G | R512P | 0.997 |
| 19:9413422:G:C | F501L | 0.997 |
| 19:9413422:G:T | F501L | 0.997 |
| 19:9413424:A:G | F501L | 0.997 |
| 19:9413565:G:C | H454D | 0.997 |
| 19:9413565:G:T | H454N | 0.997 |
| 19:9413899:G:C | H342Q | 0.997 |
| 19:9413899:G:T | H342Q | 0.997 |
| 19:9413926:A:C | F333L | 0.997 |
| 19:9413926:A:T | F333L | 0.997 |
| 19:9413928:A:G | F333L | 0.997 |
| 19:9413506:A:C | F473L | 0.996 |
| 19:9413506:A:T | F473L | 0.996 |
dbSNP variants (sampled 300 via entrez): RS1000051022 (19:9433810 A>C), RS1000112821 (19:9420207 G>T), RS1000181362 (19:9425905 G>T), RS1000236665 (19:9412573 CT>C), RS1000364053 (19:9425278 C>G), RS1000419430 (19:9431403 T>C,G), RS1000473944 (19:9423505 G>C), RS1000481146 (19:9433465 A>C), RS1000517731 (19:9421752 T>C), RS1000729504 (19:9426790 T>C,G), RS1000757637 (19:9432679 A>C), RS1000786774 (19:9424795 T>C), RS1001096007 (19:9415488 G>A,C), RS1001334767 (19:9417164 A>T), RS1001471723 (19:9416917 C>T)
Disease associations
OMIM: gene MIM:604751 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
31 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | decreases expression, decreases methylation | 3 |
| Valproic Acid | decreases expression, decreases methylation | 2 |
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | decreases expression | 1 |
| bisphenol F | affects cotreatment, decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| sodium arsenite | increases expression | 1 |
| cupric oxide | increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| K 7174 | increases expression | 1 |
| Grape Seed Proanthocyanidins | affects cotreatment, decreases expression | 1 |
| PCI 5002 | affects cotreatment, increases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Vehicle Emissions | increases abundance, increases expression | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Catechin | affects cotreatment, decreases expression | 1 |
| Dexamethasone | decreases expression, affects cotreatment | 1 |
| Dimethyl Sulfoxide | increases expression | 1 |
| Doxorubicin | increases expression | 1 |
| Ethyl Methanesulfonate | increases expression | 1 |
| Fluorouracil | affects reaction, decreases expression | 1 |
| Formaldehyde | increases expression | 1 |
| Indomethacin | affects cotreatment, decreases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Smoke | decreases expression | 1 |
| Thiram | increases expression | 1 |
| Zinc | affects cotreatment, increases expression | 1 |
| 1-Methyl-3-isobutylxanthine | decreases expression, affects cotreatment | 1 |
| Cyclosporine | increases methylation | 1 |
| Lithium Chloride | decreases expression | 1 |
| Lactic Acid | decreases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_XW26 | HEK293 eGFP-ZNF266 | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.